Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...
HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...
The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...
Scientists have found that people who carry one copy of a mutation that protects cells against HIV infection may be partially resistant to the virus causing AIDS. The new finding is reported in a ...
A small study of 156 people with COVID-19 has found that mutations that confer resistance to antiviral drugs were “commonly detected”, especially in immunocompromised patients. The authors stress that ...
Skoltech researchers and their colleagues from the Pasteur Institute and the University of Lorraine, France, have uncovered ...
Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...
The SARS-CoV-2 virus is continuously evolving and structural changes to the virus may impact the efficacy of antibody therapies and vaccines. A study describes the structural and functional landscape ...
Remdesivir has been approved as a stand-alone therapy for the treatment and prevention of Covid-19. One of the questions that arises with any single drug treatment of an RNA virus is the level of ...
The Omicron variant of COVID continues to spur governments and scientists into action this week, with booster shot programs being expanded. In response to the potentially vaccine-resistant new variant ...
New research has identified a genetic mutation that confers resistance to cassava mosaic disease (CMD). Groundbreaking research led by Rebecca Bart, PhD, associate member, and Nigel Taylor, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback